Centene price target raised to $43 from $35 at Wells Fargo

Wells Fargo raised the firm’s price target on Centene (CNC) to $43 from $35 and keeps an Equal Weight rating on the shares. For managed care organizations, the firm is most constructive on Medicare Advantage with uncertainty high for Medicaid/Exchanges. Wells sees a more difficult backdrop for hospitals in 2026 as post-COVID tailwinds wane and legislative risks near. Distributor debate remains revisions vs. multiples.